Search Orphan Drug Designations and Approvals
-
| Generic Name: | pegtarazimod |
|---|---|
| Date Designated: | 07/31/2024 |
| Orphan Designation: | treatment of acute graft-versus-host disease |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
ReAlta Life Sciences, Inc. 5665 Lowery Road #100 Norfolk, Virginia 23502 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







